DE69031080D1 - Verfahren zur herstellung von katalytischer rns in bakterien - Google Patents

Verfahren zur herstellung von katalytischer rns in bakterien

Info

Publication number
DE69031080D1
DE69031080D1 DE69031080T DE69031080T DE69031080D1 DE 69031080 D1 DE69031080 D1 DE 69031080D1 DE 69031080 T DE69031080 T DE 69031080T DE 69031080 T DE69031080 T DE 69031080T DE 69031080 D1 DE69031080 D1 DE 69031080D1
Authority
DE
Germany
Prior art keywords
rns
bacteria
producing catalytic
catalytic
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69031080T
Other languages
English (en)
Other versions
DE69031080T2 (de
Inventor
John Rossi
Nerida Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
City of Hope
Original Assignee
City of Hope
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by City of Hope filed Critical City of Hope
Publication of DE69031080D1 publication Critical patent/DE69031080D1/de
Application granted granted Critical
Publication of DE69031080T2 publication Critical patent/DE69031080T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B64—AIRCRAFT; AVIATION; COSMONAUTICS
    • B64D—EQUIPMENT FOR FITTING IN OR TO AIRCRAFT; FLIGHT SUITS; PARACHUTES; ARRANGEMENTS OR MOUNTING OF POWER PLANTS OR PROPULSION TRANSMISSIONS IN AIRCRAFT
    • B64D13/00—Arrangements or adaptations of air-treatment apparatus for aircraft crew or passengers, or freight space, or structural parts of the aircraft
    • B64D13/06—Arrangements or adaptations of air-treatment apparatus for aircraft crew or passengers, or freight space, or structural parts of the aircraft the air being conditioned
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
    • F25B11/00—Compression machines, plants or systems, using turbines, e.g. gas turbines
    • F25B11/02—Compression machines, plants or systems, using turbines, e.g. gas turbines as expanders
    • F25B11/04—Compression machines, plants or systems, using turbines, e.g. gas turbines as expanders centrifugal type
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
    • F25B9/00—Compression machines, plants or systems, in which the refrigerant is air or other gas of low boiling point
    • F25B9/002—Compression machines, plants or systems, in which the refrigerant is air or other gas of low boiling point characterised by the refrigerant
    • F25B9/004—Compression machines, plants or systems, in which the refrigerant is air or other gas of low boiling point characterised by the refrigerant the refrigerant being air
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
DE69031080T 1989-08-31 1990-10-19 Verfahren zur herstellung von katalytischer rns in bakterien Expired - Fee Related DE69031080T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40161389A 1989-08-31 1989-08-31
PCT/US1990/006032 WO1992006988A1 (en) 1989-08-31 1990-10-19 Method for the production of catalytic rna in bacteria
CA002071854A CA2071854A1 (en) 1989-08-31 1990-10-19 Method for the production of catalytic rna in bacteria

Publications (2)

Publication Number Publication Date
DE69031080D1 true DE69031080D1 (de) 1997-08-21
DE69031080T2 DE69031080T2 (de) 1998-02-26

Family

ID=25675253

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19904091533 Withdrawn DE4091533T (de) 1989-08-31 1990-06-05
DE69031080T Expired - Fee Related DE69031080T2 (de) 1989-08-31 1990-10-19 Verfahren zur herstellung von katalytischer rns in bakterien

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19904091533 Withdrawn DE4091533T (de) 1989-08-31 1990-06-05

Country Status (6)

Country Link
EP (1) EP0506666B1 (de)
JP (1) JPH05502580A (de)
AU (1) AU649975B2 (de)
CA (1) CA2071854A1 (de)
DE (2) DE4091533T (de)
WO (1) WO1992006988A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942395A (en) * 1997-05-09 1999-08-24 Universite De Montreal Hybrid ribozymes and methods of use
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
US8309791B2 (en) 2008-07-16 2012-11-13 Recombinectics, Inc. Method for producing a transgenic pig using a hyper-methylated transposon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116742A (en) * 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
EP0640688A1 (de) * 1987-12-15 1995-03-01 Gene Shears Pty. Limited Ribozyme
CA1340323C (en) * 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
DK0387775T3 (da) * 1989-03-16 1996-11-04 Boehringer Ingelheim Int Genetisk enhed til inhibering af funktionen af RNA
AU637800B2 (en) * 1989-08-31 1993-06-10 City Of Hope Chimeric dna-rna catalytic sequences
DE3929741A1 (de) * 1989-09-07 1991-03-28 Hoechst Ag Rna mit endoribonucleaseaktivitaet gegen mrna von reifungsgenen, ihre herstellung und ihre verwendung in pflanzen

Also Published As

Publication number Publication date
JPH05502580A (ja) 1993-05-13
AU649975B2 (en) 1994-06-09
EP0506666A1 (de) 1992-10-07
EP0506666A4 (en) 1993-07-14
DE4091533T (de) 1992-01-30
EP0506666B1 (de) 1997-07-16
WO1992006988A1 (en) 1992-04-30
DE69031080T2 (de) 1998-02-26
AU6616090A (en) 1992-05-20
CA2071854A1 (en) 1992-04-20

Similar Documents

Publication Publication Date Title
DE3778745D1 (de) Verfahren zur herstellung von katalysatorkoerpern.
DE3766029D1 (de) Verfahren und anlage zur herstellung von diamanten.
DE3782724D1 (de) Verfahren zur herstellung von vliesstoffen.
DE3668765D1 (de) Verfahren zur herstellung von borstenwaren und danach hergestellte borstenwaren.
ATE118498T1 (de) Verfahren zur reinigung von n- phosphonmethylglyzin.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE59006073D1 (de) Verfahren zur herstellung von azopigmenten.
DE69016460D1 (de) Verfahren zur herstellung von 2-ethylhexyl-para-methoxycinnamat.
DE68904057D1 (de) Verfahren zur herstellung fluessiger eiprodukte.
DE69002017D1 (de) Katalytisches verfahren zur herstellung von oximen.
DE69033758T2 (de) Verfahren zur herstellung von norcamphandikarbonitrilen
DE69031080D1 (de) Verfahren zur herstellung von katalytischer rns in bakterien
ATE134385T1 (de) Mikrobiologisches verfahren zur herstellung von 5-hydroxypyrazincarbonsäure
DE3875862T2 (de) Verfahren zur herstellung von supraleitenden produkten.
ATA95587A (de) Verfahren zur herstellung von glucosylmoranolin
DE3888542T2 (de) Verfahren zur herstellung von prostaglandinzwischenprodukten.
DE69022720T2 (de) Verfahren zur herstellung von dichloropentafluoropropanen.
DE59006636D1 (de) Verfahren zur herstellung von alkansulfonylbenzoesäuren.
DE58904032D1 (de) Verfahren zur herstellung von n-alkylanilinen.
DE59001780D1 (de) Verfahren zur herstellung von hydroxyanthrachinonen.
DE3580477D1 (de) Verfahren zur herstellung und reinigung von alkoxyphosphazen-polymer.
ATA81689A (de) Verfahren zur herstellung von platinkomplexen
DE59006254D1 (de) Verfahren zur herstellung von fluorbenzolen.
DE383539T1 (de) Verfahren zur herstellung von alpha-chloro-alpha-oximino-4-hydroxy-acetophenon.
DE3864702D1 (de) Verfahren zur herstellung von diagnostischen reagenzien.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HANSMANN & VOGESER, 81369 MUENCHEN

8339 Ceased/non-payment of the annual fee